Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets

Nucleic Acid Testing to Detect HBV Infection in Blood Donors

(2011) Susan L. Stramer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Infektionsepidemiologische Daten von Blutspendern in Deutschland 2007

(2010) R. Offergeld et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Performance Evaluation of the New Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test Version 2.0 for Quantification of Human Immunodeficiency Virus Type 1 RNA

(2010) S. Pas et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays

(2010) Barbara Foglieni et al.   TRANSFUSION

Performance of the New Roche Cobas AmpliPrep-Cobas TaqMan Version 2.0 Human Immunodeficiency Virus Type 1 Assay

(2009) L. Scott et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Effect of Primer-Template Mismatches on the Detection and Quantification of Nucleic Acids Using the 5′ Nuclease Assay

(2009) Ralph Stadhouders et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

TRANSFUSION COMPLICATIONS: Improvement of an ultrasensitive human immunodeficiency virus Type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region

(2009) Anke Edelmann et al.   TRANSFUSION

First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany

(2009) Michael Schmidt et al.   TRANSFUSION

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

(2009) C. Micha Nübling et al.   TRANSFUSION